Literature DB >> 35840698

An LRP6 mutation (Arg360His) associated with low bone mineral density but not cardiovascular events in a Caucasian family.

Nuria Puente1, Ana I Vega2, José L Hernandez1, Jose L Fernandez-Luna2, Jose A Riancho3.   

Abstract

We present a family with a rare mutation of the LRP6 gene and for the first time provide evidence for its association with low bone mineral density.
INTRODUCTION: The Wnt pathway plays a critical role in bone homeostasis. Pathogenic variants of the Wnt co-receptor LRP6 have been associated with abnormal skeletal phenotypes or increased risk of cardiovascular events. PATIENT AND METHODS: Here we report an index premenopausal patient and her family carrying a rare missense LRP6 pathogenic variant (rs141212743; 0.0002 frequency among Europeans). This variant has been previously associated with metabolic syndrome and atherosclerosis, in the presence of normal bone mineral density. However, the LRP6 variant was associated with low bone mineral density in this family, without evidence for association with serum lipid levels or cardiovascular events.
CONCLUSION: Thus, this novel association shows that LRP6 pathogenic variants may be involved in some cases of early-onset osteoporosis, but the predominant effect, either skeletal or cardiovascular, may vary depending on the genetic background or other acquired factors.
© 2022. The Author(s).

Entities:  

Keywords:  Bone mineral density; Genetics; LRP6; Osteoporosis; Wnt

Mesh:

Substances:

Year:  2022        PMID: 35840698      PMCID: PMC9568478          DOI: 10.1007/s00198-022-06494-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   5.071


  20 in total

Review 1.  Low-density lipoprotein receptor-related protein 6-mediated signaling pathways and associated cardiovascular diseases: diagnostic and therapeutic opportunities.

Authors:  Sheng Kang
Journal:  Hum Genet       Date:  2020-02-19       Impact factor: 4.132

2.  Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression.

Authors:  Changjun Li; Weishan Wang; Liang Xie; Xianghang Luo; Xu Cao; Mei Wan
Journal:  Ann N Y Acad Sci       Date:  2015-04-02       Impact factor: 5.691

3.  LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Authors:  Y Gong; R B Slee; N Fukai; G Rawadi; S Roman-Roman; A M Reginato; H Wang; T Cundy; F H Glorieux; D Lev; M Zacharin; K Oexle; J Marcelino; W Suwairi; S Heeger; G Sabatakos; S Apte; W N Adkins; J Allgrove; M Arslan-Kirchner; J A Batch; P Beighton; G C Black; R G Boles; L M Boon; C Borrone; H G Brunner; G F Carle; B Dallapiccola; A De Paepe; B Floege; M L Halfhide; B Hall; R C Hennekam; T Hirose; A Jans; H Jüppner; C A Kim; K Keppler-Noreuil; A Kohlschuetter; D LaCombe; M Lambert; E Lemyre; T Letteboer; L Peltonen; R S Ramesar; M Romanengo; H Somer; E Steichen-Gersdorf; B Steinmann; B Sullivan; A Superti-Furga; W Swoboda; M J van den Boogaard; W Van Hul; M Vikkula; M Votruba; B Zabel; T Garcia; R Baron; B R Olsen; M L Warman
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

4.  Idiopathic Juvenile Osteoporosis: Clinical Experience from a Single Centre and Screening of LRP5 and LRP6 Genes.

Authors:  Roberto Franceschi; Monica Vincenzi; Marta Camilot; Franco Antoniazzi; Anthony J Freemont; Judith E Adams; Christine Laine; Outi Makitie; M Zulf Mughal
Journal:  Calcif Tissue Int       Date:  2015-03-18       Impact factor: 4.333

5.  A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene.

Authors:  Wendy Balemans; Erna Cleiren; Ulrike Siebers; Jürgen Horst; Wim Van Hul
Journal:  Bone       Date:  2005-06       Impact factor: 4.398

6.  Wnt co-receptors Lrp5 and Lrp6 differentially mediate Wnt3a signaling in osteoblasts.

Authors:  Aimy Sebastian; Nicholas R Hum; Deepa K Murugesh; Sarah Hatsell; Aris N Economides; Gabriela G Loots
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

7.  Clinical Phenotype and Relevance of LRP5 and LRP6 Variants in Patients With Early-Onset Osteoporosis (EOOP).

Authors:  Julian Stürznickel; Tim Rolvien; Alena Delsmann; Sebastian Butscheidt; Florian Barvencik; Stefan Mundlos; Thorsten Schinke; Uwe Kornak; Michael Amling; Ralf Oheim
Journal:  J Bone Miner Res       Date:  2020-11-12       Impact factor: 6.741

Review 8.  Wnt Pathway in Bone Repair and Regeneration - What Do We Know So Far.

Authors:  Khosrow S Houschyar; Christian Tapking; Mimi R Borrelli; Daniel Popp; Dominik Duscher; Zeshaan N Maan; Malcolm P Chelliah; Jingtao Li; Kamran Harati; Christoph Wallner; Susanne Rein; Dominik Pförringer; Georg Reumuth; Gerrit Grieb; Sylvain Mouraret; Mehran Dadras; Johannes M Wagner; Jungul Y Cha; Frank Siemers; Marcus Lehnhardt; Björn Behr
Journal:  Front Cell Dev Biol       Date:  2019-01-07

9.  Comprehensive Genetic Analysis of 128 Candidate Genes in a Cohort With Idiopathic, Severe, or Familial Osteoporosis.

Authors:  Manuela G M Rocha-Braz; Monica M França; Adriana M Fernandes; Antonio M Lerario; Evelin A Zanardo; Lucas S de Santana; Leslie D Kulikowski; Regina M Martin; Berenice B Mendonca; Bruno Ferraz-de-Souza
Journal:  J Endocr Soc       Date:  2020-10-07

10.  A role for the MEGF6 gene in predisposition to osteoporosis.

Authors:  Craig C Teerlink; Michael J Jurynec; Rolando Hernandez; Jeff Stevens; Dana C Hughes; Cherie P Brunker; Kerry Rowe; David J Grunwald; Julio C Facelli; Lisa A Cannon-Albright
Journal:  Ann Hum Genet       Date:  2020-10-07       Impact factor: 1.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.